Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Robert T. Brodell MD, FAAD Editor-in-Chief

Jane M. Grant-Kels MD, FAAD Advisory Board

Sarah L. Chamlin MD Advisory Board

See All Experts

Published in Dermatology

News · April 06, 2022

AAD 2022: Apremilast May Aid Cardiometabolic Health in Patients With Psoriasis

New phase 4 data show apremilast tied to some improvement in cardiometabolic biomarkers and significant reductions in visceral, subcutaneous fat

PracticeUpdate Editorial Team

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

featured

Rebound Growth of Infantile Hemangiomas After Discontinuation of Treatment With Propranolol vs Atenolol

Dermatology (Basel) · November 29, 2024
featured

Allergic Contact Cheilitis/Stomatitis Owing to Beverages and Food

Contact Derm · November 28, 2024
story of the week

Assessing Skin Cancer Diagnosis Accuracy by Lesion Type, Physician Experience, and Examination Method

JAMA Dermatol · November 27, 2024
featured

Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention

JAMA Dermatol · November 27, 2024
story of the week

Association Between 5α-Reductase Inhibitor Use for Dermatologic Conditions and the Risk of Breast or Gynecologic Cancers

J Am Acad Dermatol · November 26, 2024

updated
featured

Efficacy of Treatment With Secukinumab in Patients With Hidradenitis Suppurativa

J Eur Acad Dermatol Venereol · November 26, 2024

updated
story of the week

Local Recurrence, Metastasis, and Mortality Rates Among Patients With Thin and In Situ Melanomas

J Am Acad Dermatol · November 26, 2024

updated
featured

Suicidal and Self-Injurious Behaviors Among Patients With Psoriasis or Psoriatic Arthritis Treated With Biologics

J Am Acad Dermatol · November 26, 2024

updated
featured

Efficacy and Safety of Combined Topical 17α-Ethinyl Estradiol With Minoxidil vs Topical Minoxidil Alone in Patients With Female Pattern Hair Loss

Clin Exp Dermatol · November 26, 2024

updated
featured

Clinical Features and Treatment Outcomes Among Patients With Primary Cutaneous B-Cell Lymphomas

Int. J. Dermatol · November 21, 2024
featured

Clinical Characteristics and Outcomes of DPP-4 Inhibitor–Associated Bullous Pemphigoid

J Am Acad Dermatol · November 21, 2024

AAD 2022: Apremilast May Aid Cardiometabolic Health in Patients With Psoriasis

Further Reading

Rebound Growth of Infantile Hemangiomas After Discontinuation of Treatment With Propranolol vs Atenolol

Allergic Contact Cheilitis/Stomatitis Owing to Beverages and Food

Assessing Skin Cancer Diagnosis Accuracy by Lesion Type, Physician Experience, and Examination Method

Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention

Association Between 5α-Reductase Inhibitor Use for Dermatologic Conditions and the Risk of Breast or Gynecologic Cancers

Efficacy of Treatment With Secukinumab in Patients With Hidradenitis Suppurativa

Local Recurrence, Metastasis, and Mortality Rates Among Patients With Thin and In Situ Melanomas

Suicidal and Self-Injurious Behaviors Among Patients With Psoriasis or Psoriatic Arthritis Treated With Biologics

Efficacy and Safety of Combined Topical 17α-Ethinyl Estradiol With Minoxidil vs Topical Minoxidil Alone in Patients With Female Pattern Hair Loss

Clinical Features and Treatment Outcomes Among Patients With Primary Cutaneous B-Cell Lymphomas

Clinical Characteristics and Outcomes of DPP-4 Inhibitor–Associated Bullous Pemphigoid

Recently Updated